Notably, C431A, T173A, T240M and P294S mutations of Parkin that inhibit Parkin’s E3 ligase activity for HIF-1α (Fig. 4d, h) significantly impaired the ability of Parkin to inhibit migration and invasion of breast cancer cells (Fig. 6g). This evidence concerns the gene PRKN and breast carcinoma.